Making sense of AI : bias, trust and transparency in pharma R&D - Drug Target Review
A core principle of the Act is its classification of certain AI systems, especially those in healthcare and drug development, as “high- risk .” This is ...
Read the original at Drug Target Review ↗
- Topics
- HealthcareBias & Fairness
- Tracked via
- “AI Risks”